UnitedHealth Group Incorporated (UNH)
| Market Cap | 282.20B |
| Revenue (ttm) | 435.16B |
| Net Income (ttm) | 17.59B |
| Shares Out | 905.84M |
| EPS (ttm) | 19.22 |
| PE Ratio | 16.21 |
| Forward PE | 18.61 |
| Dividend | $8.84 (2.84%) |
| Ex-Dividend Date | Dec 8, 2025 |
| Volume | 7,336,986 |
| Open | 310.81 |
| Previous Close | 309.09 |
| Day's Range | 310.00 - 314.75 |
| 52-Week Range | 234.60 - 622.83 |
| Beta | 0.43 |
| Analysts | Buy |
| Price Target | 407.88 (+30.92%) |
| Earnings Date | Oct 28, 2025 |
About UNH
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children’s health insurance and health... [Read more]
Financial Performance
In 2024, UnitedHealth Group's revenue was $400.28 billion, an increase of 7.71% compared to the previous year's $371.62 billion. Earnings were $14.41 billion, a decrease of -35.64%.
Financial StatementsAnalyst Summary
According to 25 analysts, the average rating for UNH stock is "Buy." The 12-month stock price target is $407.88, which is an increase of 30.92% from the latest price.
News
UnitedHealth: Buy Before The Buybacks Resume
While the market fixates on UnitedHealth's buyback pause as a sign of distress, a granular analysis of the balance sheet reveals a highly calculable, yet overlooked, path to deleveraging. Investors ar...
UnitedHealth is dropping a million seniors from Medicare Advantage as it aims to restore its ‘swagger'
America's largest insurer is making sweeping changes to its Medicare Advantage plans to improve profit margins.
UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board
UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.
What Could Ignite UNH Stock's Next Major Rally?
UnitedHealth stock (NYSE: UNH) has faced significant pressure this year, creating a potential setup for a major rally.
Former FDA commissioner Scott Gottlieb joins UnitedHealth board
UnitedHealth Group said on Tuesday former U.S. Food and Drug Administration commissioner Scott Gottlieb has joined the company's board of directors.
Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors
--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group's (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb,...
Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH
The Investment Committee give you their top stocks to watch for the second half.
UnitedHealth's Rally Still Has Legs, Further Margin Recovery Through 2027
UNH has highlighted numerous bold strategies with the aim of driving margin recovery through 2027, mostly through raised premiums along with benefit adjustments and targeted plan exits. Despite the po...
Can UnitedHealth Still Claim The Top Spot?
UnitedHealth Group stock (NYSE: UNH) has declined by 7% over the past month. This downturn is attributed to several significant investor concerns, including rising medical costs within its Medicare Ad...
Final Trade: UNH, OIH, AMD, BMY
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.
UnitedHealth Group Incorporated (UNH) Presents at UBS Global Healthcare Conference 2025 Transcript
UnitedHealth Group Incorporated ( UNH) UBS Global Healthcare Conference 2025 November 10, 2025 8:45 AM EST Company Participants Julie Murphy Wayne DeVeydt - Chief Financial Officer Conference Call Pa...
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
Health Insurer Stocks Wounded by Trump Comments, UNH Options Trade
Truth Social comments from President Trump against health care insurers sent stocks like Centene (CNC), HCA Healthcare (HCA), and Molina Healthcare (MOH) plunging Monday morning. Marley Kayden takes a...
Virtus SGA Global Growth Q3 2025 Portfolio Positioning
We reviewed and maintained our UnitedHealth position through its underwriting crisis, recognizing that management's mispricing of annually renewable policies could be corrected through swift action. O...
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
--(BUSINESS WIRE)--UNH Board Authorizes Payment of Quarterly Dividend.
UnitedHealth Group: Absorbing Cost-Pressures Is A Key Competitive Advantage
UnitedHealth Group (UNH) remains bullish, supported by strong EPS guidance, cost-cutting via AI, and premium increases well below sector averages. UNH's strategy to absorb cost pressures instead of pa...
Buy Or Sell United Health Stock?
UnitedHealth (UNH) shares have dropped 10% over the last week and are presently trading at $330.83. We believe there are only a few aspects to be wary of in UNH stock, considering its overall Moderate...
UnitedHealth: The Market Is Still Worried, And That's Good For Buyers
UnitedHealth Group is showing solid signs of stabilization after July's capitulation, with Berkshire's investment boosting sentiments and a resilient Q3 performance lending a calming influence. UNH's ...
UnitedHealth Group Q3: Why Strong Money Holds At $323
UnitedHealth Group remains a buy, supported by recent super-investor accumulation and their holding price. Super-investors, including Berkshire Hathaway and Michael Burry, currently hold UNH shares at...
UnitedHealth: A Glimmer Of Future Growth Is Still There
UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround under new leadership. UNH's new management, led by returning CEO Stephen H...
UNH - 3 Reasons Not To Buy After 'Beat & Raise'
United Health (UNH) has rebounded from its lows but remains well below previous highs, attracting value investors seeking mean reversion. Q3 earnings beat expectations modestly, with adjusted EPS and ...
UnitedHealth: Risk-Reward Profile Signals Time To Hold, Not Buy (Rating Downgrade)
UnitedHealth Group delivered better-than-expected Q3 results, beating earnings estimates and raising guidance. UNH faces ongoing profitability pressures from elevated medical utilization and regulator...
Calls of the Day: Uber, Datadog, UnitedHealth, Chubb and FTAI Aviation
The Investment Committee debate the latest Calls of the Day.
Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
UnitedHealth: Strong Long-Term Fundamentals, But Risks Also Exist
UnitedHealth Group has outperformed the S&P 500 since my previous Buy and Strong Buy ratings, delivering 33% and 41% total returns. Following Q3 FY2025 earnings review, UNH remains the most expensive ...